2 Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
4 Study Confirms Widespread Presence Of Nectin-4 Target In Head And Neck Cancer, ADC Drug In Play! Mar 17, 2025
Read More Apparatus The New Generation Of Breast Cancer SERD Drug, Elastoxan, Shows Promise! Mar 22, 2025
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
Read More Apparatus New Discovery: Drug For Parkinson's Disease That May Reduce Chemotherapy Side Effects And Boost Cancer-Fighting Power! Apr 03, 2025
